These agents include semaglutide (Ozempic for diabetes, Wegovy for obesity), liraglutide (Victoza for diabetes, Saxenda for obesity), dulaglutide (Trulicity, diabetes only), and tirzepatide (Mounjaro for diabetes, Zepbound for obesity)with tirzepatide being a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist
CJC-1295 without DAC (Modified GRF 1-29) CJC-1295 without DAC goes by several names: Modified GRF (1-29), Mod GRF, or tetrasubstituted GRF (1-29)
Benefits: Boosts immune system Supports bone and muscle health Improves mood and energy levels 5
Recent advances in genetically modified animal models of glaucoma and their roles in drug repositioning
IV therapy is a tool, not a cure-all
While they share similar properties, R-ALA is considered more potent and effective due to its higher bioavailability and efficacy